25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.

Amir, Eitan; Cecchini, Reena S; Ganz, Patricia A; Costantino, Joseph P; Beddows, Samantha; Hood, Nicola; Goodwin, Pamela J

Amir, Eitan; Cecchini, Reena S; Ganz, Patricia A; Costantino, Joseph P; Beddows, Samantha; Hood, Nicola; Goodwin, Pamela J.

Affiliation

Amir E; Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, ON, Canada.

Breast Cancer Res Treat ; 133(3): 1077-88, 2012 Jun.

Article in En | MEDLINE | ID: mdl-22415479

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Breast Neoplasms/epidemiology; Obesity/complications; Tamoxifen/therapeutic use; Vitamin D/analogs & derivatives; Adult; Aged; Body Mass Index; Breast Neoplasms/blood; Breast Neoplasms/prevention & control; C-Reactive Protein/metabolism; Case-Control Studies; Female; Humans; Insulin/blood; Leptin/blood; Middle Aged; Odds Ratio; Risk; Vitamin D/blood

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Vitamin D / Breast Neoplasms / Antineoplastic Agents, Hormonal / Obesity Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2012 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google